GAMMA Investing LLC Increases Stake in Azenta, Inc. (NASDAQ:AZTA)

GAMMA Investing LLC boosted its position in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 4,054.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 65,019 shares of the company's stock after buying an additional 63,454 shares during the period. GAMMA Investing LLC owned 0.14% of Azenta worth $2,252,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of AZTA. Picton Mahoney Asset Management lifted its holdings in shares of Azenta by 305.7% in the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock valued at $35,000 after purchasing an additional 532 shares in the last quarter. Headlands Technologies LLC acquired a new position in shares of Azenta in the 4th quarter worth approximately $40,000. Covestor Ltd lifted its holdings in shares of Azenta by 64.2% in the 4th quarter. Covestor Ltd now owns 2,043 shares of the company's stock worth $102,000 after purchasing an additional 799 shares during the last quarter. Quarry LP bought a new stake in Azenta during the 4th quarter valued at $110,000. Finally, Sterling Capital Management LLC raised its stake in Azenta by 39.8% during the 4th quarter. Sterling Capital Management LLC now owns 2,856 shares of the company's stock valued at $143,000 after acquiring an additional 813 shares in the last quarter. Institutional investors and hedge funds own 99.08% of the company's stock.

Wall Street Analysts Forecast Growth

AZTA has been the topic of a number of recent research reports. TD Cowen upgraded Azenta to a "hold" rating in a report on Thursday, February 27th. Needham & Company LLC lowered their price target on Azenta from $59.00 to $40.00 and set a "buy" rating on the stock in a research note on Wednesday, May 7th.

Azenta Stock Performance

NASDAQ:AZTA opened at $30.60 on Friday. The stock's fifty day moving average price is $27.32 and its two-hundred day moving average price is $39.37. The company has a market cap of $1.40 billion, a price-to-earnings ratio of -10.27 and a beta of 1.62. Azenta, Inc. has a 52-week low of $23.91 and a 52-week high of $63.58.

Azenta (NASDAQ:AZTA - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.05 EPS for the quarter, missing analysts' consensus estimates of $0.09 by ($0.04). Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. The business's quarterly revenue was up 5.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.06 earnings per share. On average, equities analysts predict that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.